Jiangsu Simcere Pharmaceutical Co., Ltd
  • Seen : 754 View
Rate :
  • Address : 699-18 Xuanwu Avenue Nanjing China
  • About us : We are rapidly transitioning to an innovation and R&D-driven pharmaceutical company, with a mission of “providing today’s patients with medicines of the future.” We focus on oncology, central nervous system disease and autoimmune disease therapeutic areas.We have established R&D centers in Shanghai, Nanjing and Boston. With the approval of the Ministry of Scienc ...
    More
  • About us :

    We are rapidly transitioning to an innovation and R&D-driven pharmaceutical company, with a mission of “providing today’s patients with medicines of the future.” We focus on oncology, central nervous system disease and autoimmune disease therapeutic areas.We have established R&D centers in Shanghai, Nanjing and Boston. With the approval of the Ministry of Science and Technology, we have also established a National Key Laboratory of Translational Medicine and Innovative Pharmaceuticals . We have been continuously recognized as one of the “Top 10 Innovative Pharmaceutical Enterprises in China” and “Top 100 Pharmaceutical Manufacturing Enterprises of China ”. We were listed on the Hong Kong Stock Exchange in 2020.

    Close
Products
Endostar®:Recombinant Human Endostatin Injection
ENWEIDA:Envafolimab Injection
Enlength®:Bortezomib for Injection
Sinofuan®:Fluorouracil Implants
JIEBAILI®:Pemetrexed Disodium for Injection
Enlighten:Bendamustine Hydrochloride for Injection
Ancozy®:Trazodone Hydrochloride Tablets
BICUN®:Edaravone Injection
Sanbexin®:Edaravone and Dexborneol Concentrated Solution for Injection
AIJIEWEI®:Tofacitinib Citrate Tablets
YEQING®:Zanamivir Dry Powder for Inhalation
Newanti®:Biapenem for Injection